Korean Journal of Otorhinolaryngology-Head and Neck Surgery

Korean Society of Otolaryngology-Head and Neck Surgery (대한이비인후과학회)
권호 표지
DOI QR코드

DOI QR Code

Spasmodic Dysphonia

연축성 발성장애

  • Yang, Yun-Su (Department of Otolaryngology-Head and Neck Surgery, Chonbuk National University Medical School)
  • 양윤수 (전북대학교 의과대학 이비인후-두경부외과학교실)
  • Published : 2010.09.25
⟨ Previous Next ⟩

Abstract

Spasmodic dysphonia is a primary task specific focal dystonia affecting the laryngeal muscle during speech. Adductor spasmodic dysphonia (ADSD) affects close to 90% of spasmodic dysphonia patients is characterized by voice breaks during vowels during speech due to intermittent hyperadduction of the vocal folds. Abcuctor spasmodic dysphonia (ABSD) is relatively rare and involves intermittent voiceless voice breaks due to prolonged voiceless consonants before initiation of the following vowels. Treatment for spasmodic dysphonia has been aimed at denervation or adjustment of the larynx to prevent the uncontrolled spasms in the laryngeal muscles from interfering with voice production. As a result there is a risk-benefit ratio in that the denervation must be adequate to reduce the detection of symptoms whereas at the same time not producing aphonia, breathiness and swallowing difficulties. This article summarizes the pathogenesis, diagnosis and treatment of the spasmodic dysphonia.

Keywords

References

  1. Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surgery 2008;139(4):495-505. https://doi.org/10.1016/j.otohns.2008.05.624
  2. National Spasmodic Dysphonia Association, Spasmodic dysphonia, Available from: URL: http://www.dysphonia.org/nsda/spasmodic.
  3. Henschen TL, Burton NG. Treatment of spastic dysphonia by EMG biofeedback. Biofeedback Self Regul 1978;3(1):91-6. https://doi.org/10.1007/BF00998566
  4. Ludlow CL, Mann EA. Management of spasmodic dysphonia. In: Rubin J, Sataloff R, Korovin G, editors. Diagnosis and Treatment of Voice Disorders. Vol. 2. San Diego: Singular;2000.
  5. Pearson EJ, Sapienza CM. Historical approaches to the treatment of Adductor-Type Spasmodic Dysphonia (ADSD): review and tutorial. Neuro Rehabilitation 2003;18(4):325-38.
  6. Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Adv Neurol 2004;94:163-70.
  7. Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, et al. Decreased [18F]spiperone binding in putamen in dystonia. Adv Neurol 1998;78:161–8.
  8. Todd RD, Carl J, Harmon S, O'Malley KL, Perlmutter JS. Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons. J Neurosci 1996;16(23):7776-82.
  9. Cohen LG, Ludlow CL, Warden M, Estegui M, Agostino R, Sedory SE, et al. Blink reflex excitability recovery curves in patients with spasmodic dysphonia. Neurology 1989;39(4):572-7. https://doi.org/10.1212/WNL.39.4.572
  10. Ibanez V, Sadato N, Karp B, Deiber MP, Hallett M. Deficient activation of the motor cortical network in patients with writer's cramp. Neurology 1999;53(1):96–105. https://doi.org/10.1212/WNL.53.1.96
  11. Butefisch CM, Boroojerdi B, Chen R, Battaglia F, Hallett M. Taskdependent intracortical inhibition is impaired in focal hand dystonia. Mov Disord 2005;20(5):545–51. https://doi.org/10.1002/mds.20367
  12. Sohn YH, Hallett M. Surround inhibition in human motor system. Exp Brain Res 2004;158(4):397-404.
  13. Boroojerdi B, Cohen LG, Hallett M. Effects of botulinum toxin on motor system excitability in patients with writer's cramp. Neurology 2003;61(11):1546-50. https://doi.org/10.1212/01.WNL.0000095965.36574.0F
  14. Zeuner KE, Shill HA, Sohn YH, Molloy FM, Thornton BC, Dambrosia JM, et al. Motor training as treatment in focal hand dystonia. Mov Disord 2005;20(3):335-41. https://doi.org/10.1002/mds.20314
  15. Quartarone A, Bagnato S, Rizzo V, Siebner HR, Dattola V, Scalfari A, et al. Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain 2003;126(Pt 12):2586-96. https://doi.org/10.1093/brain/awg273
  16. Quartarone A, Siebner HR, Rothwell JC. Task-specific hand dystonia: can too much plasticity be bad for you? Trends Neurosci 2006;29(4):192-9. https://doi.org/10.1016/j.tins.2006.02.007
  17. Bara-Jimenez W, Shelton P, Sanger TD, Hallett M. Sensory discrimination capabilities in patients with focal hand dystonia. Ann Neurol 2000;47(3):377-80. https://doi.org/10.1002/1531-8249(200003)47:3<377::AID-ANA16>3.0.CO;2-2
  18. Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C. Abnormal somatosensory homunculus in dystonia of the hand. Ann Neurol 1998;44(5):828-31. https://doi.org/10.1002/ana.410440520
  19. Tempel LW, Perlmutter JS. Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia. Brain 1990;113(Pt 3):691-707. https://doi.org/10.1093/brain/113.3.691
  20. Ludlow CL, Schulz GM, Yamashita T, Deleyiannis FW. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol. 1995;104(12):928-35. https://doi.org/10.1177/000348949510401203
  21. Sant'Ambrogio G. Afferent pathways for the cough reflex. Bull Eur Physiopathol Respir 1987;23 Suppl 10:19s-23s.
  22. Davis PJ, Nail BS. Quantitative analysis of laryngeal mechanosensitivity in the cat and rabbit. J Physiol 1987;388:467-85. https://doi.org/10.1113/jphysiol.1987.sp016625
  23. Mathew OP, Sant'Ambrogio FB, Sant'Ambrogio G. Laryngeal paralysis on receptor and reflex responses to negative pressure in the upper airway. Respir Physiol 1988;74(1):25-34. https://doi.org/10.1016/0034-5687(88)90137-5
  24. Sant'Ambrogio G, Brambilla-Sant'Ambrogio F, Mathew OP. Effect of cold air on laryngeal mechanoreceptors in the dog. Respir Physiol 1986;64(1):45-56. https://doi.org/10.1016/0034-5687(86)90059-9
  25. Sant'Ambrogio G, Anderson JW, Sant'Ambrogio FB, Mathew OP. Response of laryngeal receptors to water solutions of different osmolality and ionic composition. Respir Med 1991;85 Suppl A:57-60.
  26. Sant'Ambrogio G, Mathew OP, Sant'Ambrogio FB. Role of intrinsic muscles and tracheal motion in modulating laryngeal receptors. Respir Physiol 1985;61(3):289-300. https://doi.org/10.1016/0034-5687(85)90072-6
  27. Sessle BJ. Excitatory and inhibitory inputs to single neurones in the solitary tract nucleus and adjacent reticular formation. Brain Res 1973;53(2):319-31. https://doi.org/10.1016/0006-8993(73)90217-5
  28. Ambalavanar R, Tanaka Y, Selbie WS, Ludlow CL. Neuronal activation in the medulla oblongata during selective elicitation of the laryngeal adductor response. J Neurophysiol 2004;92(5):2920-32. https://doi.org/10.1152/jn.00064.2004
  29. Sasaki CT, Suzuki M. Laryngeal reflexes in cat, dog and man. Arch Otolaryngol 1976;102(7):400-2. https://doi.org/10.1001/archotol.1976.00780120048004
  30. Wani MK, Woodson GE. Paroxysmal laryngospasm after laryngeal nerve injury. Laryngoscope 1999;109(5):694-7. https://doi.org/10.1097/00005537-199905000-00003
  31. Ambalavanar R, Purcell L, Miranda M, Evans F, Ludlow CL. Selective suppression of late laryngeal adductor responses by N-methyl-Dasparate receptor blockade in the cat. J Neurophysiol 2002;87(3):1252-62. https://doi.org/10.1152/jn.00595.2001
  32. Kearney PR, Poletto CJ, Mann EA, Ludlow CL. Suppression of thyroarytenoid muscle responses during repeated air pressure stimulation of the laryngeal mucosa in awake humans. Ann Otol Rhinol Laryngol 2005;114(4):264-70. https://doi.org/10.1177/000348940511400403
  33. Haslinger B, Erhard P, Dresel C, Castrop F, Roettinger M, Ceballos-Baumann AO. "Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology 2005;65(10):1562-9. https://doi.org/10.1212/01.wnl.0000184478.59063.db
  34. Ali SO, Thomassen M, Schulz GM, Hosey LA, Varga M, Ludlow CL, et al. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res 2006;49(5):1127-46. https://doi.org/10.1044/1092-4388(2006/081)
  35. Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, et al. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci 1997;17(2):843-50.
  36. Ludlow CL. Treatment for spasmodic dysphonia: limitation of current approaches. Curr Opin Otolaryngol Head Neck Surg 2009;17(3):160-5. https://doi.org/10.1097/MOO.0b013e32832aef6f
  37. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85(4 Pt 1):451-9. https://doi.org/10.1177/000348947608500405
  38. Atkins JP. An electromyographic study of recurrent laryngeal nerve conduction and its clinical application. Laryngoscope 1973;83(5):796-807. https://doi.org/10.1288/00005537-197305000-00015
  39. Netterville JL, Stone RE, Rainey C, Zealear DL, Ossoff RH. Recurrent laryngeal nerve avulsion for treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol 1991;100(1):10-4. https://doi.org/10.1177/000348949110000102
  40. Shaw GY, Sechtem PR, Rideout B. Posterior cricoarytenoid myoplasty with medialization thyroplasty in the management of refractory abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2003;112(4):303-6. https://doi.org/10.1177/000348940311200403
  41. Berke GS, Blackwell KE, Gerratt RR, Verneil A, Jackson KS, Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999;108(3):227-31. https://doi.org/10.1177/000348949910800302
  42. Isshiki N. Recent advances in phonosurgery. Folia Phoniat (Basel) 1980; 32(2):119-54. https://doi.org/10.1159/000264334
  43. Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988;98(6 Pt 1):636-40.
  44. Chhetri DK, Mendelsohn AH, Blumin JH, Berke GS. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia. Laryngoscope 2006;116(4):635-42. https://doi.org/10.1097/01.MLG.0000201990.97955.E4
  45. Chan SW, Baxter M, Oates J, Yorston A. Long-term results of type II thyroplasty for adductor spasmodic dysphonia. Laryngoscope 2004;114(9):1604-8. https://doi.org/10.1097/00005537-200409000-00019
  46. Remacle M, Plouin-Gaudon I, Lawson G, Abitbol J. Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases. Eur Arch Otorhinolaryngol 2005;262(10):871-4. https://doi.org/10.1007/s00405-004-0897-7
  47. Kim HS, Choi HS, Lim JY, Choi YL, Lim SE. Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it. Clin Otolaryngol 2008;33(6):621-5. https://doi.org/10.1111/j.1749-4486.2008.01777.x
  48. Nakamura K, Muta H, Watanabe Y, Mochizuki R, Yoshida T, Suzuki M. Surgical treatment for adductor spasmodic dysphonia--efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy. Acta Otolaryngol 2008;128(12):1348-53. https://doi.org/10.1080/00016480801965019
  49. Tsuji DH, Chrispim FS, Imamura R, Sennes LU, Hachiya A. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia. Braz J Otorhinolaryngol 2006;72(2):261-6. https://doi.org/10.1016/S1808-8694(15)30066-5
  50. Sanuki T, Isshiki N. Outcomes of type II thyroplasty for adductor spasmodic dysphonia: analysis of revision and unsatisfactory cases. Acta Otolaryngol 2008:1-7.
  51. Choi HS, Moon HJ, Kim HY, Kim SC, Kim KM. Effect of botulinum toxin injection in patients with adductor spasmodic dysphonia. J Korean Otolaryngol-Head Neck Surg 1997;40(4):475-80.
  52. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108(10):1435-41. https://doi.org/10.1097/00005537-199810000-00003
  53. Truong DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101(6 Pt 1):630-4.
  54. Castellanos PF, Gates GA, Esselman G, Song F, Vannier MW, Kuo M. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia. Laryngoscope 1994;104(6 Pt 1):656-62.
  55. Bielamowicz S, Squire S, Bidus K, Ludlow CL. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2001;110(5 Pt 1): 406-12. https://doi.org/10.1177/000348940111000503

Cited by

  1. 음성진전 유무에 따른 내전형 연축성 발성장애의 보툴리눔 독소-A 주입 후 음성 특성 변화 양상 vol.4, pp.4, 2012, https://doi.org/10.13064/ksss.2012.4.4.095